Cannabis Science, Inc. Financial Analysis ReviewSummaryCannabis Science, Inc. (formerly, Gulf Onshore, Inc.) is a public traded, pharmaceutical company that is engaged in the development, manufacturing and commercialization of phytocannabinoid based pharmaceutical products. Cannabis is focused on developing a wide range of effective whole plant cannabinoid based pharmaceutical products for a wide variety of important applications, including, nausea, AIDS, cancer, chronic pain, crohn's disease, pain and neuropathic pain. Cannabinoids are a group of terpenophenolic compounds present in Cannabis (Cannabis sativa L). The company is headquartered at Colorado Springs in Colorado, the US. Global Market Directs Financial Analysis Review is an essential source for data, analysis and insight into Cannabis Science, Inc. . It examines the companys business structure and operations, products and services. The report provides information regarding key data, details on key executives and the major locations and subsidiaries of the company. It also provides key financial ratios for the company.Scope The report includes key company information such as business description, products and services, and key suppliers and competitors. It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters. Ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy A quick one-stop-shop to understand the company. Get an in depth understanding of companys recent and historical financial performance. Get the latest metrics on companys performance. Support sales activities by understanding your customers businesses better Qualify prospective partners and suppliers. Understand and respond to your competitors business structure, strategy and prospects.
|
